Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

SCI Pharmtech Corp. (4119) Financial Statements

SCI Pharmtech Corp. Financial Overview

SCI Pharmtech Corp.'s market cap is currently NT$5.85B. The company's EPS TTM is NT$0.51; its P/E ratio is 95.69; and it has a dividend yield of 1.55%. SCI Pharmtech Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 1.34BNT$ 1.52BNT$ 1.20BNT$ 899.74MNT$ 864.22M
Gross ProfitNT$ 319.47MNT$ 410.67MNT$ 350.32MNT$ 291.18MNT$ 208.09M
Operating IncomeNT$ 155.25MNT$ 198.28MNT$ 160.30MNT$ 404.30MNT$ 63.30M
EBITDANT$ 408.21MNT$ 909.92MNT$ 515.77MNT$ 492.07MNT$ 142.81M
Net IncomeNT$ 107.37MNT$ 534.68MNT$ 294.72MNT$ 308.78MNT$ 55.70M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 74.80MNT$ 692.76MNT$ 1.03BNT$ 264.37MNT$ 692.63M
Total AssetsNT$ 6.89BNT$ 7.20BNT$ 6.69BNT$ 4.96BNT$ 4.19B
Total DebtNT$ 987.18MNT$ 990.39MNT$ 1.04BNT$ 545.38MNT$ 2.15M
Net DebtNT$ 926.56MNT$ 408.00MNT$ 100.42MNT$ 378.55MNT$ -330.08M
Total LiabilitiesNT$ 1.49BNT$ 1.72BNT$ 1.59BNT$ 1.33BNT$ 869.26M
Stockholders' EquityNT$ 5.39BNT$ 5.48BNT$ 5.10BNT$ 3.63BNT$ 3.32B
Cash Flow
Free Cash FlowNT$ -389.68MNT$ -86.12MNT$ -813.59MNT$ -871.02MNT$ -494.70M
Operating Cash FlowNT$ 220.32MNT$ 860.52MNT$ 215.77MNT$ 296.56MNT$ 280.28M
Investing Cash FlowNT$ -512.92MNT$ -1.01BNT$ -866.20MNT$ -1.01BNT$ -539.56M
Financing Cash FlowNT$ -229.15MNT$ -210.84MNT$ 1.43BNT$ 547.12MNT$ -41.52M

Currency in TWD

SCI Pharmtech Corp. Earnings and Revenue History

01B2B3B0 %15 %30 %45 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

SCI Pharmtech Corp. Liabilities to Assets

03B6B9B8 %16 %24 %32 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

SCI Pharmtech Corp. Cash Flow

-1.5B-1B-500M0500M1B1.5B2B201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

SCI Pharmtech Corp. Forecast EPS vs Actual EPS

-0.2-0.100.10.20.30.40.5Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >